Cargando…

The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes

OBJECTIVE: Increasing uptake of cancer screening is a priority for health systems internationally, however, some patients may not attend because they are undergoing active treatment for the cancer of interest or have other medical reasons that mean participation would be inappropriate. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Mead, L, Porteous, L, Tait, M, Stoker, R, Payne, S, Calvert, C, Maxwell, D, Katikireddi, SV
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429165/
https://www.ncbi.nlm.nih.gov/pubmed/25753487
http://dx.doi.org/10.1177/0969141315572173
_version_ 1782370992682696704
author Mead, L
Porteous, L
Tait, M
Stoker, R
Payne, S
Calvert, C
Maxwell, D
Katikireddi, SV
author_facet Mead, L
Porteous, L
Tait, M
Stoker, R
Payne, S
Calvert, C
Maxwell, D
Katikireddi, SV
author_sort Mead, L
collection PubMed
description OBJECTIVE: Increasing uptake of cancer screening is a priority for health systems internationally, however, some patients may not attend because they are undergoing active treatment for the cancer of interest or have other medical reasons that mean participation would be inappropriate. This study aims to quantify the proportion of non-participants who have a medical reason for not attending cancer screening. METHODS: Medical reasons for not participating in breast and bowel screening were defined a priori on the basis of a literature review and expert opinion. The notes of 700 patients at two GP practices in Scotland were reviewed, to ascertain the prevalence of medical reasons amongst non-participants. Simple proportions and confidence intervals were calculated. RESULTS: 17.4% of breast and 2.3% of bowel screening non-participants had a medical reason to not participate. The two most common reasons were previous breast cancer follow up (8.86%) and recent mammogram (6.57%). CONCLUSION: These patients may not benefit from screening while also being distressed by receiving an invitation. This issue also makes accurate monitoring and target-setting for improving uptake difficult. Further work is needed to estimate robustly the extent to which medical reasons account for screening non-participation in a larger population.
format Online
Article
Text
id pubmed-4429165
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-44291652015-05-31 The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes Mead, L Porteous, L Tait, M Stoker, R Payne, S Calvert, C Maxwell, D Katikireddi, SV J Med Screen Short Communications OBJECTIVE: Increasing uptake of cancer screening is a priority for health systems internationally, however, some patients may not attend because they are undergoing active treatment for the cancer of interest or have other medical reasons that mean participation would be inappropriate. This study aims to quantify the proportion of non-participants who have a medical reason for not attending cancer screening. METHODS: Medical reasons for not participating in breast and bowel screening were defined a priori on the basis of a literature review and expert opinion. The notes of 700 patients at two GP practices in Scotland were reviewed, to ascertain the prevalence of medical reasons amongst non-participants. Simple proportions and confidence intervals were calculated. RESULTS: 17.4% of breast and 2.3% of bowel screening non-participants had a medical reason to not participate. The two most common reasons were previous breast cancer follow up (8.86%) and recent mammogram (6.57%). CONCLUSION: These patients may not benefit from screening while also being distressed by receiving an invitation. This issue also makes accurate monitoring and target-setting for improving uptake difficult. Further work is needed to estimate robustly the extent to which medical reasons account for screening non-participation in a larger population. SAGE Publications 2015-06 /pmc/articles/PMC4429165/ /pubmed/25753487 http://dx.doi.org/10.1177/0969141315572173 Text en © The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm).
spellingShingle Short Communications
Mead, L
Porteous, L
Tait, M
Stoker, R
Payne, S
Calvert, C
Maxwell, D
Katikireddi, SV
The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
title The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
title_full The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
title_fullStr The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
title_full_unstemmed The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
title_short The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes
title_sort prevalence of medical reasons for non-participation in the scottish breast and bowel cancer screening programmes
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429165/
https://www.ncbi.nlm.nih.gov/pubmed/25753487
http://dx.doi.org/10.1177/0969141315572173
work_keys_str_mv AT meadl theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT porteousl theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT taitm theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT stokerr theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT paynes theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT calvertc theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT maxwelld theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT katikireddisv theprevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT meadl prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT porteousl prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT taitm prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT stokerr prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT paynes prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT calvertc prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT maxwelld prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes
AT katikireddisv prevalenceofmedicalreasonsfornonparticipationinthescottishbreastandbowelcancerscreeningprogrammes